Peter Helt Jacobsen Haahr
Directeur Général chez LEO Holding A/S (Denmark)
Profil
Peter Helt Jacobsen Haahr is currently the Chief Executive Officer at LEO Fondet and LEO Holding A.
He is also a Director at Leo Pharma, Inc., Sonion Holdco A, Xellia Holdco A, Novo Invest 1 A, Env Holdcoco AS, Novo Capital Investors ApS, Novo Capital Investors PS, Novo Invest 2 AS, Novo Invest 2A A, Novo Invest 2B AS, and Novo Invest 2C AS.
Previously, he was the Chairman at House of Denmark A, Deputy Chairman at NNIT A, Director at Symphogen A, and Head-Investor Relations at Novo Nordisk A.
He also served as the Chief Financial Officer at Novo Holdings A from 2016 to 2021.
Mr. Haahr holds an MBA from the International Institute for Management Development and a graduate degree from Aarhus Business College.
Postes actifs de Peter Helt Jacobsen Haahr
| Sociétés | Poste | Début |
|---|---|---|
House of Denmark A/S
 House of Denmark A/S Food: Specialty/CandyConsumer Non-Durables House of Denmark A/S offers product including dried fruit, biscuits, cakes, and fruit snacks. The firm provides products for children consist of fruit mix, raisins, and fruit bars in various practical packaging. The company was founded in 2002 and is headquartered in Vejle Ost, Denmark. | Président | 02/04/2002 |
| Novo Capital Investors PS | Directeur/Membre du Conseil | - |
| Novo Capital Investors ApS | Directeur/Membre du Conseil | - |
Novo Invest 1 A/S
 Novo Invest 1 A/S Financial ConglomeratesFinance Novo Invest 1 A/S provides investment services. The private company is based in Hellerup, Denmark. | Directeur/Membre du Conseil | - |
Novo Invest 2 AS
 Novo Invest 2 AS Financial ConglomeratesFinance Novo Invest 2 AS functions as an investment holding Danish company. | Directeur/Membre du Conseil | - |
| Novo Invest 2A A/S | Directeur/Membre du Conseil | - |
Novo Invest 2B AS
 Novo Invest 2B AS Financial ConglomeratesFinance Novo Invest 2B AS is an investment holding Danish company. | Directeur/Membre du Conseil | - |
Novo Invest 2C AS
 Novo Invest 2C AS Financial ConglomeratesFinance Novo Invest 2C AS is an investment holding Danish company. | Directeur/Membre du Conseil | - |
Env Holdcoco AS
 Env Holdcoco AS Financial ConglomeratesFinance Env Holdcoco AS is an investment holding Danish company. | Directeur/Membre du Conseil | - |
| ░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Peter Helt Jacobsen Haahr
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░ | - |
Formation de Peter Helt Jacobsen Haahr
| Aarhus Business College | Graduate Degree |
| International Institute for Management Development | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| NNIT A/S | Technology Services |
| Entreprise privées | 17 |
|---|---|
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings A/S (Investment Company) (Novo Holdings-IC) is the investment portfolio division of Novo Holdings A/S, a holding company headquartered in Hellerup, Denmark. They are ultimately owned by Novo Nordisk Fonden (Novo Nordisk Foundation). Founded in 1999, Novo Holdings-IC manages a broad portfolio of the Foundation’s financial assets. | Finance |
House of Denmark A/S
House of Denmark A/S Food: Specialty/CandyConsumer Non-Durables House of Denmark A/S offers product including dried fruit, biscuits, cakes, and fruit snacks. The firm provides products for children consist of fruit mix, raisins, and fruit bars in various practical packaging. The company was founded in 2002 and is headquartered in Vejle Ost, Denmark. | Consumer Non-Durables |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Health Technology |
| Novo Capital Investors PS | |
| Novo Capital Investors ApS | |
Novo Invest 1 A/S
Novo Invest 1 A/S Financial ConglomeratesFinance Novo Invest 1 A/S provides investment services. The private company is based in Hellerup, Denmark. | Finance |
Novo Invest 2 AS
Novo Invest 2 AS Financial ConglomeratesFinance Novo Invest 2 AS functions as an investment holding Danish company. | Finance |
| Novo Invest 2A A/S | |
Novo Invest 2B AS
Novo Invest 2B AS Financial ConglomeratesFinance Novo Invest 2B AS is an investment holding Danish company. | Finance |
Novo Invest 2C AS
Novo Invest 2C AS Financial ConglomeratesFinance Novo Invest 2C AS is an investment holding Danish company. | Finance |
Env Holdcoco AS
Env Holdcoco AS Financial ConglomeratesFinance Env Holdcoco AS is an investment holding Danish company. | Finance |
| Xellia Holdco A/S | |
Sonion Holdco A/S
 Sonion Holdco A/S Financial ConglomeratesFinance Part of Sonion A/S, Sonion Holdco A/S is an investment holding Danish company. The company is based in Hellerup, Denmark. | Finance |
LEO Fondet
 LEO Fondet BiotechnologyHealth Technology LEO Fondet provides support for research in the fields of medicine, chemistry, and pharmacy. The company was founded on August 20, 1984 and is headquartered in Ballerup, Denmark. | Health Technology |
LEO Holding A/S (Denmark)
 LEO Holding A/S (Denmark) Financial ConglomeratesFinance LEO Holding A/S invests in company with interest in medical dermatology. The company was founded on November 29, 2017 and is headquartered in Copenhagen, Denmark. | Finance |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Leo Pharma, Inc.
 Leo Pharma, Inc. Drugstore ChainsRetail Trade Leo Pharma, Inc. is engaged in the development, manufacture, and marketing of pharmaceutical drugs. Its products are used for dermatologic and thrombotic patients. The company was founded in 1908 and is headquartered in Parsippany, NJ. | Retail Trade |